BIONDVAX PHARMACEUTICALS-ADR (BVXV)
US09073Q2049 - ADR
ChartMill assigns a Buy % Consensus number of 83% to BVXV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 39.78. This target is 2825% above the current price.
BVXV was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BVXV.
In the previous month the buy percentage consensus was at a similar level.
BVXV was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-01-26 | Aegis Capital | Initiate | Buy |